Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

Laura Mannonen; Hannimari Kallio-Kokko; Raisa Loginov; Anu Jääskeläinen; Pia Jokela; Jenni Antikainen; Paula Väre; Eliisa Kekäläinen; Satu Kurkela; Hanna Jarva; Maija Lappalainen

doi:10.1016/j.jmoldx.2021.01.005

Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

Laura Mannonen, Hannimari Kallio-Kokko, Raisa Loginov, Anu Jääskeläinen, Pia Jokela, Jenni Antikainen, Paula Väre, Eliisa Kekäläinen, Satu Kurkela, Hanna Jarva, Maija Lappalainen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Journal of Molecular Diagnostics
Volym	23
Nummer	4
Sidor (från-till)	407-416
Antal sidor	10
ISSN	1525-1578
DOI	https://doi.org/10.1016/j.jmoldx.2021.01.005
Status	Publicerad - apr. 2021
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3111 Biomedicinska vetenskaper

Åtkomst av dokument

10.1016/j.jmoldx.2021.01.005

PIIS1525157821000076Slutlig publicerad version, 433 KBLicens: CC BY-NC-ND
Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNAKorrektur, 377 KBLicens: CC BY-NC-ND

Citera det här

Mannonen, L., Kallio-Kokko, H., Loginov, R., Jääskeläinen, A., Jokela, P., Antikainen, J., Väre, P., Kekäläinen, E., Kurkela, S., Jarva, H., & Lappalainen, M. (2021). Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA. Journal of Molecular Diagnostics, 23(4), 407-416. https://doi.org/10.1016/j.jmoldx.2021.01.005

@article{dd5253bd8f684203aa8c2c774a37b5f8,

title = "Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA",

keywords = "3111 Biomedicine",

author = "Laura Mannonen and Hannimari Kallio-Kokko and Raisa Loginov and Anu J{\"a}{\"a}skel{\"a}inen and Pia Jokela and Jenni Antikainen and Paula V{\"a}re and Eliisa Kek{\"a}l{\"a}inen and Satu Kurkela and Hanna Jarva and Maija Lappalainen",

year = "2021",

month = apr,

doi = "10.1016/j.jmoldx.2021.01.005",

language = "English",

volume = "23",

pages = "407--416",

journal = "Journal of Molecular Diagnostics",

issn = "1525-1578",

publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",

number = "4",

}

Mannonen, L , Kallio-Kokko, H , Loginov, R , Jääskeläinen, A , Jokela, P , Antikainen, J, Väre, P, Kekäläinen, E , Kurkela, S , Jarva, H & Lappalainen, M 2021, 'Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA', Journal of Molecular Diagnostics, vol. 23, nr. 4, s. 407-416. https://doi.org/10.1016/j.jmoldx.2021.01.005

Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA. / Mannonen, Laura ; Kallio-Kokko, Hannimari ; Loginov, Raisa et al.

I: Journal of Molecular Diagnostics, Vol. 23, Nr. 4, 04.2021, s. 407-416.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

AU - Mannonen, Laura

AU - Kallio-Kokko, Hannimari

AU - Loginov, Raisa

AU - Jääskeläinen, Anu

AU - Jokela, Pia

AU - Antikainen, Jenni

AU - Väre, Paula

AU - Kekäläinen, Eliisa

AU - Kurkela, Satu

AU - Jarva, Hanna

AU - Lappalainen, Maija

PY - 2021/4

Y1 - 2021/4

KW - 3111 Biomedicine

U2 - 10.1016/j.jmoldx.2021.01.005

DO - 10.1016/j.jmoldx.2021.01.005

M3 - Article

VL - 23

SP - 407

EP - 416

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 4

ER -